A Oveta Fuller

Title: A Oveta Fuller: Innovator in Therapeutics Against HSV Infection

Introduction

A Oveta Fuller is a notable inventor based in Dexter, MI (US). She has made significant contributions to the field of therapeutics, particularly in the fight against herpes simplex virus (HSV) infections. Her innovative work has led to the development of methods and compositions that enhance the identification and testing of therapeutics.

Latest Patents

Fuller holds a patent for "Compositions and methods for identifying and testing therapeutics." This invention provides compositions and methods for identifying and testing therapeutics against HSV infection. It includes compositions comprising receptors that enable cell-specific entry of HSV. Additionally, the invention features a novel DNA sequence that encodes a protein B5T74, which allows HSV to infect and replicate in otherwise non-permissive cells. The patent also describes vectors that comprise isolated nucleic acids encoding HSV receptors, fragments of the HSV receptors, or homologs of the HSV receptor. Furthermore, it introduces a porcine cell system that expresses a herpes simplex virus receptor but does not express endogenous HSV entry receptors.

Career Highlights

Fuller is affiliated with the University of Michigan, where she continues her research and development in the field of therapeutics. Her work has been instrumental in advancing the understanding of HSV and developing potential treatments.

Collaborations

Fuller has collaborated with notable colleagues, including Aleida Perez and Ning-hun C McLaren. These partnerships have contributed to her research and the successful development of her patented inventions.

Conclusion

A Oveta Fuller is a pioneering inventor whose work in therapeutics against HSV infection has the potential to make a significant impact in the medical field. Her innovative approaches and collaborations highlight her dedication to advancing healthcare solutions.